Toyama, Tatsuya http://orcid.org/0000-0003-4713-7795
Yoshimura, Akiyo
Hayashi, Takako
Kobayashi, Naomi
Saito, Kanako
Tsuneizumi, Michiko
Sawaki, Masataka
Hattori, Masaya
Nakada, Takumi
Yokota, Isao
Iwata, Hiroji
Funding for this research was provided by:
Chugai Pharmaceutical
Article History
Received: 2 February 2018
Accepted: 6 June 2018
First Online: 8 June 2018
Compliance with ethical standards
:
: TT received a research grant from AstraZeneca, and Chugai Pharmaceutical Co., Ltd. HI received an honorarium from Chugai Pharmaceutical Co., Ltd., and AstraZeneca, and research funding for the development of new drugs from MSD K.K., AstraZeneca, Kyowa Hakko Kirin Co., Ltd., GSK, Daiichi-Sankyo Co., Ltd., Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Novartis Pharma K.K., Bayer Yakuhin Ltd., and Pfizer Japan Inc. No other authors have conflicts of interest to declare.